District Court: Incorporation by Reference for Purposes of Anticipation Requires More than a Parenthetical

March 13, 2025

Reading Time : 2 min

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

This patent infringement case involved patents directed to methods for detecting nucleic acids. Defendant advanced two anticipation defenses, both of which were premised on the incorporation of material from one reference into another. Specifically, defendant contended that the asserted patents were anticipated by either (i) the Larsson Dissertation incorporating by reference the Göransson article, or (ii) the Gunderson article incorporating by reference the Levsky article.

Plaintiffs moved in limine under FRE 402 and 403 to preclude defendant from these arguments, contending both anticipation defenses relied on material that was not adequately incorporated by reference. In their motion, plaintiffs noted that the Larsson Dissertation included citations to 131 different publications in its text, but only cited to Göransson three times. Similarly, the text of Gunderson referenced Levsky only once in a parenthetical. Plaintiffs contended that these were “routine academic citations” that failed to make clear what material was being incorporation into the primary reference. 

The court agreed with plaintiffs regarding Gunderson, and held that the lone textual citation to Levsky did not identify any specific material from Levsky that was being incorporated into Gunderson. Although Gunderson described the contents of Levsky in a parenthetical, this was, in the court’s view, the equivalent of a “bare footnote” that fell short of the detailed particularity required for incorporation. The court therefore precluded defendant from presenting any testimony or arguments regarding the Gunderson/Levsky defense.

The court reached the opposite conclusion regarding the Larsson Dissertation and its incorporation of Göransson. In so doing, the court pointed out that the Larsson Dissertation substantively discusses Göransson in three passages, including specific teachings about its strategies and methods for detecting nucleic acids. The court also credited the unrebutted testimony by defendant’s expert discussing each of those instances and explaining that one skilled in the art would have understood the Larsson Dissertation to incorporate specific teachings from Göransson. 

 Practice Tip: When considering an anticipation theory premised on incorporation by reference, a defendant should carefully evaluate whether the primary reference includes specific discussion of the secondary reference and clearly identifies where that subject matter is found. A defendant advancing such a theory should also consider having an expert describe each instance where the secondary reference is mentioned and provide an opinion as to whether a person of ordinary skill in the art would have understood the primary reference to have incorporated the specific teachings from the secondary reference.

Case: 10X Genomics, Inc. et al. v. Vizgen Inc., 1:22-cv-00595 (DDE Jan. 30, 2025) (Kennelly)

 

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.